X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11) 11
female (9) 9
index medicus (9) 9
male (9) 9
middle aged (8) 8
aged (7) 7
adult (6) 6
aged, 80 and over (5) 5
celecoxib (5) 5
oncology (5) 5
treatment outcome (5) 5
adolescent (4) 4
cancer (4) 4
dose-response relationship, drug (4) 4
child, preschool (3) 3
colorectal neoplasms - prevention & control (3) 3
drug administration schedule (3) 3
follow-up studies (3) 3
adenoma - prevention & control (2) 2
adolescents (2) 2
allergic rhinitis (2) 2
angiogenesis inhibitors (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
article (2) 2
aspirin use (2) 2
camptothecin - administration & dosage (2) 2
camptothecin - analogs & derivatives (2) 2
cardiovascular diseases - chemically induced (2) 2
care and treatment (2) 2
chemoprevention (2) 2
child (2) 2
clinical neurology (2) 2
colorectal neoplasms - drug therapy (2) 2
complications (2) 2
confidence intervals (2) 2
cyclooxygenase 2 inhibitors - therapeutic use (2) 2
dacarbazine - administration & dosage (2) 2
dacarbazine - analogs & derivatives (2) 2
double-blind method (2) 2
gastroenterology & hepatology (2) 2
gastroenterology and hepatology (2) 2
gastrointestinal toxicity (2) 2
histamine (2) 2
hypertension (2) 2
inhibition (2) 2
kaplan-meier estimate (2) 2
mathematics (2) 2
medicine & public health (2) 2
medicine, general & internal (2) 2
naproxen (2) 2
neoplasms - drug therapy (2) 2
nonsteroidal antiinflammatory drugs (2) 2
nose (2) 2
olopatadine (2) 2
osteoarthritis (2) 2
plus temozolomide (2) 2
prevention (2) 2
pyrazoles - therapeutic use (2) 2
randomized controlled trials as topic (2) 2
randomized-trial (2) 2
renal-cell carcinoma (2) 2
rheumatoid-arthritis (2) 2
rheumatology (2) 2
rhinitis (2) 2
risk (2) 2
risk assessment (2) 2
studies (2) 2
sulfonamides - therapeutic use (2) 2
temozolomide (2) 2
tyrosine kinase inhibitor (2) 2
young adult (2) 2
1st-line treatment (1) 1
5-year outcomes (1) 1
8-drugs-in-1-day regimen (1) 1
abridged index medicus (1) 1
adenoma (1) 1
adenoma - drug therapy (1) 1
adenoma - genetics (1) 1
adenomatous polyposis coli - drug therapy (1) 1
adenomatous polyposis coli - prevention & control (1) 1
adjuvant temozolomide (1) 1
administration, oral (1) 1
advanced breast-cancer (1) 1
age factors (1) 1
allelic variants (1) 1
alpha (1) 1
analysis (1) 1
anaplastic astrocytoma (1) 1
anaplastic oligodendroglioma (1) 1
angiogenesis inhibitor (1) 1
angiogenesis inhibitors - adverse effects (1) 1
animals (1) 1
anti-inflammatory agents, non-steroidal - adverse effects (1) 1
anti-inflammatory agents, non-steroidal - pharmacology (1) 1
anti-inflammatory drugs (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - therapeutic use (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 02/2018, Volume 141, Issue 2, pp. AB170 - AB170
Rationale In two randomized double-blind studies, twice-daily GSP301 nasal spray-a fixed-dose combination of olopatadine hydrochloride and mometasone... 
Studies | Histamine | Rhinitis | Allergic rhinitis | Nose | Olopatadine
Journal Article
Journal Article
The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 02/2018, Volume 141, Issue 2, pp. AB173 - AB173
Rationale Combining an intranasal antihistamine with an intranasal corticosteroid for the treatment of allergic rhinitis (AR) may provide improved symptom... 
Histamine | Rhinitis | Allergic rhinitis | Nose | Olopatadine
Journal Article
Journal Article
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 3/2016, Volume 77, Issue 3, pp. 527 - 538
PF-00337210 is an oral, highly selective vascular endothelial growth factor receptor (VEGFR) inhibitor. We evaluated a composite of biomarkers in real time to... 
DCEMRI imaging | Medicine & Public Health | Tyrosine kinase inhibitor | Oncology | Cancer Research | Pharmacodynamic analysis | VEGF receptor | Pharmacology/Toxicology | 1ST-LINE TREATMENT | ADVANCED BREAST-CANCER | ANTITUMOR-ACTIVITY | RENAL-CELL CARCINOMA | FACTOR RECEPTOR INHIBITOR | LUNG-CANCER | ONCOLOGY | COLORECTAL-CANCER | PHARMACOLOGY & PHARMACY | ANGIOGENESIS INHIBITOR | ENDOTHELIAL GROWTH-FACTOR | Humans | Middle Aged | Biomarkers, Pharmacological | Magnetic Resonance Imaging - methods | Benzofurans - administration & dosage | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Quinolines - administration & dosage | Dose-Response Relationship, Drug | Young Adult | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Antineoplastic Agents - adverse effects | Aged, 80 and over | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Adult | Female | Benzofurans - therapeutic use | Drug Administration Schedule | Treatment Outcome | Benzofurans - adverse effects | Neoplasms - drug therapy | Maximum Tolerated Dose | Aged | Quinolines - therapeutic use | Neoplasms - pathology | Quinolines - adverse effects | Hypertension | Medical research | Care and treatment | Medicine, Experimental | Hemoglobin | Vascular endothelial growth factor | Tumors | Index Medicus
Journal Article
Cancer Prevention Research, ISSN 1940-6207, 04/2009, Volume 2, Issue 4, pp. 310 - 321
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 5/2013, Volume 113, Issue 1, pp. 127 - 134
Journal Article
Gastroenterology, ISSN 0016-5085, 2009, Volume 136, Issue 7, pp. 2127 - 2136.e1
Journal Article
Neuro-Oncology, ISSN 1522-8517, 09/2013, Volume 15, Issue 9, pp. 1236 - 1243
Journal Article
01/1998, ISBN 9780599025820
Of concern is the linear or semilinear differential equation$$ u\sp{\prime\prime}(t) = F(t,u(t),u\sp\prime(t))\eqno(1)$$for u mapping $\lbrack 0,\infty)$ to a... 
Mathematics
Dissertation
Journal Article
01/1998, ISBN 9780599025813
Consider a quantum mechanical atom with N electrons and Z protons. The electrons are situated in $\IR\sp3,$ and the protons are in the fixed nucleus which we... 
Mathematics
Dissertation
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.